CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...